… both effectiveness and safety. Sixth, this study only included treatment-… apixaban and
warfarin patients because a comparison between patients who switched from warfarin to apixaban …

… Because apixaban has benefits over warfarin that are consistent across patient risk of stroke
… less relevant when used to tailor apixaban treatment to individual patients than they are for …

… the safety and efficacy of apixaban compared with warfarin in … to warfarin, our findings
suggest that apixaban is a safe and … in patients with ESRD maintained on dialysis, with apixaban …

… In this study, we have shown that this also applies for the subgroup of patients ≥75 years:
apixaban was superior to warfarin across the range of estimated GFR, with no significant …

… patients to treatment with apixaban or dose-adjusted warfarin. The primary objective was to
determine whether apixaban was noninferior to warfarin … embolism among patients with atrial …

… effects of apixaban relative to those of warfarin extend to patients with provoked VTE. … safety
of apixaban versus warfarin were maintained in other subgroup analyses, including patients …

… safety and effectiveness of apixaban versus warfarin in patients with severe renal impairment.
… of this study was to evaluate the safety and effectiveness of apixaban versus warfarin in …

… patients treated with oral anticoagulation (OAC). We hypothesized that HD patients treated
with apixaban … compared to those treated with warfarin. We further hypothesized that this risk …

… that directly compares the efficacy and safety of all 3 NOACs (ie, apixaban, dabigatran, and
… the efficacy and safety of apixaban, dabigatran, and rivaroxaban with warfarin in Asians with …

… In the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial … ) trial
comparing apixaban and warfarin in patients with AF, apixaban was superior to warfarin in …